AI diagnostics, drug discovery, clinical decision support, medical imaging, mental health chatbots, and the promise and peril of applying AI to human health — where the stakes of getting it wrong are measured in lives.
A patient walked into a doctor's office last week and was asked if they were comfortable with AI listening to the appointment. They said no. The doctor clarified: it was just speech-to-text software, the kind that's been transcribing medical notes since before the iPhone existed.…
A Bluesky user walked into their GP's office last week and was asked if they consented to AI listening in on the consultation. They said no. The doctor clarified: it was just speech-to-text software, the kind that's existed for decades, rebranded under the AI umbrella because eve…
A new AI model from Mayo Clinic can detect pancreatic cancer on routine CT scans years before clinical diagnosis, setting a new benchmark for early-stage screening and forcing a reevaluation of current diagnostic pathways.
Mayo Clinic's AI detects pancreatic cancer on CT scans up to three years early.
This breakthrough offers a path to curative treatment for a deadly disease.
The finding redefines early detection benchmarks, shifting medical expectations for diagnostic AI.
AI's expanding presence in healthcare workflows increasingly disguises its role, creating a control problem where clinicians are asked to trust systems whose active state is obscured.
AI tools are becoming covert agents in clinical settings, operating without explicit clinician awareness.
The core problem shifts from AI performance to the opacity of its presence and operational state.
Clinicians are forced to trust systems they cannot verify, increasing the risk of automation bias.
AI-powered skin apps are creating a clinical dilemma, simultaneously driving up unnecessary visits for benign lesions and failing to detect actual cancers, undermining trust in AI diagnostics.
AI skin apps create a liability through both false positives and missed cancer diagnoses.
Clinical trust in AI diagnostics is eroding due to inconsistent real-world performance.
The conversation is shifting to AI as an "augmented intelligence" tool, not a standalone diagnostic.
Patient preference for human interaction is now the decisive factor in AI adoption within clinical settings, forcing individual practitioners to choose between efficiency and trust.
Patient preference for human interaction is defining AI adoption in healthcare.
Individual doctors are prioritizing perceived care quality over AI efficiency.
Bottom-up patient and clinician choices are now outpacing institutional AI mandates.
{{beat:ai-in-healthcare|AI in Healthcare}} conversation volume more than doubled in 24 hours — hitting 2,150 posts compared to a 900-post daily average — yet the recent voices in the data contain no single event, announcement, or viral post driving the spike. The discourse appear…
AI diagnostic tools are rapidly advancing in specialized medical fields, but this speed bypasses fundamental health equity issues, risking wider disparities as commercial priorities outpace equitable access.
AI diagnostic tools are rapidly advancing in specialized medical areas.
This innovation is not prioritizing equitable health outcomes.
The current commercial focus risks widening existing healthcare disparities.